136 related articles for article (PubMed ID: 27543124)
1. Diagnostic Utility of Acoustic Structure Quantification for Evaluation of Radiation Sialadenitis after Radioactive Iodine Therapy.
Jeong SH; Hong HS; Lee EH
Ultrasound Med Biol; 2016 Nov; 42(11):2553-2561. PubMed ID: 27543124
[TBL] [Abstract][Full Text] [Related]
2. Radioiodine-Induced Salivary Gland Damage Detected by Ultrasonography in Patients Treated for Papillary Thyroid Cancer: Radioactive Iodine Activity and Risk.
Horvath E; Skoknic V; Majlis S; Tala H; Silva C; Castillo E; Whittle C; Niedmann JP; González P
Thyroid; 2020 Nov; 30(11):1646-1655. PubMed ID: 32370663
[No Abstract] [Full Text] [Related]
3. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.
Jeong SY; Kim HW; Lee SW; Ahn BC; Lee J
Thyroid; 2013 May; 23(5):609-16. PubMed ID: 23153322
[TBL] [Abstract][Full Text] [Related]
4. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment.
Caglar M; Tuncel M; Alpar R
Clin Nucl Med; 2002 Nov; 27(11):767-71. PubMed ID: 12394122
[TBL] [Abstract][Full Text] [Related]
5. Prediction of risk for symptomatic sialadenitis by post-therapeutic dual (131)I scintigraphy in patients with differentiated thyroid cancer.
Lee SM; Lee JW; Kim SY; Han SW; Bae WK
Ann Nucl Med; 2013 Oct; 27(8):700-9. PubMed ID: 23921836
[TBL] [Abstract][Full Text] [Related]
6. Using Acoustic Structure Quantification During B-Mode Sonography for Evaluation of Hashimoto Thyroiditis.
Rhee SJ; Hong HS; Kim CH; Lee EH; Cha JG; Jeong SH
J Ultrasound Med; 2015 Dec; 34(12):2237-43. PubMed ID: 26543169
[TBL] [Abstract][Full Text] [Related]
7. Effects of Salivary Secretion Stimulation on the Treatment of Chronic Radioactive Iodine-Induced Sialadenitis.
Choi JS; Hong SB; Hyun IY; Lim JY; Kim YM
Thyroid; 2015 Jul; 25(7):839-45. PubMed ID: 25809840
[TBL] [Abstract][Full Text] [Related]
8. Radioactive iodine and the salivary glands.
Mandel SJ; Mandel L
Thyroid; 2003 Mar; 13(3):265-71. PubMed ID: 12729475
[TBL] [Abstract][Full Text] [Related]
9. Salivary gland dysfunction after radioactive iodine (I-131) therapy in patients following total thyroidectomy: emphasis on radioactive iodine therapy dose.
Lee HN; An JY; Lee KM; Kim EJ; Choi WS; Kim DY
Clin Imaging; 2015; 39(3):396-400. PubMed ID: 25630229
[TBL] [Abstract][Full Text] [Related]
10. Salivary gland function after sialendoscopy for treatment of chronic radioiodine-induced sialadenitis.
Kim YM; Choi JS; Hong SB; Hyun IY; Lim JY
Head Neck; 2016 Jan; 38(1):51-8. PubMed ID: 24995941
[TBL] [Abstract][Full Text] [Related]
11. Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer.
Ma C; Xie J; Chen Q; Wang G; Zuo S
Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD007956. PubMed ID: 19821441
[TBL] [Abstract][Full Text] [Related]
12. Association of Xerostomia and Ultrasonographic Features of the Major Salivary Glands After Radioactive Iodine Ablation for Papillary Thyroid Carcinoma.
Soo Roh S; Wook Kim D; Jin Baek H
AJR Am J Roentgenol; 2016 Nov; 207(5):1077-1081. PubMed ID: 27504709
[TBL] [Abstract][Full Text] [Related]
13. Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy.
Raza H; Khan AU; Hameed A; Khan A
Nucl Med Commun; 2006 Jun; 27(6):495-9. PubMed ID: 16710103
[TBL] [Abstract][Full Text] [Related]
14. Salivary gland injury resulting from exposure to radioactive iodine: case reports.
Mandel L; Liu F
J Am Dent Assoc; 2007 Dec; 138(12):1582-7. PubMed ID: 18056102
[TBL] [Abstract][Full Text] [Related]
15. [Salivary gland damage after 131I therapy in patients with differentiated thyroid cancer. Preliminary report].
Macioszek A; Baczyk M; Kopeć T; Sowiński J
Endokrynol Pol; 2008; 59(5):403-10. PubMed ID: 18979451
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors for radioactive iodine-induced sialadenitis.
Sánchez Barrueco A; González Galán F; Alcalá Rueda I; Santillán Coello JM; Barrio Dorado MP; Villacampa Aubá JM; Escanciano Escanciano M; Llanos Jiménez L; Mahillo Fernández I; Cenjor Español C
Acta Otolaryngol; 2020 Nov; 140(11):959-962. PubMed ID: 32815758
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland dysfunction and nasolacrimal duct obstruction: stenotic changes following I-131 therapy.
Savage MW; Sobel RK; Hoffman HT; Carter KD; Finkelstein MW; Shriver EM
Ophthalmic Plast Reconstr Surg; 2015; 31(3):e50-2. PubMed ID: 24836449
[TBL] [Abstract][Full Text] [Related]
18. Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer.
Almeida JP; Sanabria AE; Lima EN; Kowalski LP
Head Neck; 2011 May; 33(5):686-90. PubMed ID: 21484917
[TBL] [Abstract][Full Text] [Related]
19. Iodide mumps: a case report of complicated radioactive iodine causing sialadenitis.
Lei L; Velasco O; Nobay F
Am J Emerg Med; 2012 Mar; 30(3):512.e5-6. PubMed ID: 21354757
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonographic Features of the Major Salivary Glands after Radioactive Iodine Ablation in Patients with Papillary Thyroid Carcinoma.
Kim DW
Ultrasound Med Biol; 2015 Oct; 41(10):2640-5. PubMed ID: 26215493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
